Medication · Medication
ADHD Stimulants
Prescription stimulants for attention-deficit/hyperactivity disorder.
- Last revised
- 0
- graded outcomes
- 0
- references listed
A medication reference built from the interaction graph. It is not prescribing information — the label and your prescriber are.
What is uncertain
Read off the same rows as above. Nothing here is added that the entry does not itself record.
- Caution with Phenylpiracetam: Additive stimulation.
- Caution with Yohimbine: Additive cardiovascular strain and anxiety.
- Caution with Caffeine: Additive stimulation and cardiovascular strain on top of prescription stimulants.
- Caution with Rhodiola Rosea: Activating adaptogen plus a stimulant — stack low or not at all.
Interactions
Documented pairings with supplements and medicines. A medicine on this list is a conversation for whoever prescribes it.
PhenylpiracetamCaution
Additive stimulation.
YohimbineCaution
Additive cardiovascular strain and anxiety.
CaffeineCaution
Additive stimulation and cardiovascular strain on top of prescription stimulants.
Rhodiola RoseaCaution
Activating adaptogen plus a stimulant — stack low or not at all.
The evidence in words
What it is
Prescription stimulants for attention-deficit/hyperactivity disorder.
How it works
They raise dopamine and norepinephrine signaling; other stimulants add cardiovascular strain.
What it's used for
ADHD, narcolepsy.
Supplement & drug interactions
ADHD Stimulants has 4 documented interactions mapped below and in the interactions graph. Stimulant-stacking is the theme: caffeine and activating adaptogens (rhodiola) add cardiovascular load and jitter. Tyrosine (a catecholamine precursor) is sometimes used but should be cleared. Avoid combining with MAOIs.
The rule
This is a medication reference for spotting interactions, not dosing advice. Every change to a supplement stack around a prescription belongs with the person who prescribes it.
Related reading
Entries that share this one's tags or conditions.
- Anticoagulants (Warfarin)Warfarin is a vitamin-K-antagonist anticoagulant with a narrow therapeutic window measured by INR.Evidence grade A
- AntiplateletsDrugs that reduce platelet clumping to prevent arterial clots.Evidence grade A
- Blood-Pressure MedicationsThe families of drugs that lower blood pressure — ACE inhibitors, ARBs, calcium-channel blockers, beta-blockers.Evidence grade A
- DOACsDirect oral anticoagulants — newer blood thinners that, unlike warfarin, need no routine INR monitoring.Evidence grade A
Sources
This entry lists no references of its own.
Last revised . A grade is this entry's reading of the evidence, not medical advice.